Skip to content
bluejethealthcare.com
About Us
Company Overview
Our Journey
Board of Directors
News and Media
Business Segments
Contrast Media Intermediates
Artificial Sweetners
Protected Amino Acid & Derivatives
CDMO-Pharma Intermediates & APIs
Capabilities
R & D Capabilities
Reaction Capabilities
Manufacturing Capabilities
EHS
Investor Relations
Notices
Investor Presentation
Dividend Details
Stock Exchange Communication
Financial Information
Annual Return
Annual Report
Corporate Governance
Board Committees
Governance Policies
Related Party Transactions
Prospectus / MOA / AOA
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
AGM / EGM
Credit Rating
Annual Secretarial Compliance Report
Prospectus
Contact Us
About Us
Company Overview
Our Journey
Board of Directors
News and Media
Business Segments
Contrast Media Intermediates
Artificial Sweetners
Protected Amino Acid & Derivatives
CDMO-Pharma Intermediates & APIs
Capabilities
R & D Capabilities
Reaction Capabilities
Manufacturing Capabilities
EHS
Investor Relations
Notices
Investor Presentation
Dividend Details
Stock Exchange Communication
Financial Information
Annual Return
Annual Report
Corporate Governance
Board Committees
Governance Policies
Related Party Transactions
Prospectus / MOA / AOA
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
AGM / EGM
Credit Rating
Annual Secretarial Compliance Report
Prospectus
Contact Us
Shareholding Pattern
FY 2025-26
?
Shareholding Pattern Q1
Shareholding Pattern Q2
Shareholding Pattern Q3
Shareholding Pattern Q4
2024-2025
Shareholding Pattern Q1
Shareholding Pattern Q2
Shareholding Pattern Q3
Shareholding Pattern Q4
2023-2024
Shareholding Pattern PreListing
Shareholding pattern Q3
Q4 Shareholding Pattern
2023-2024
Shareholding Pattern PreListing
Shareholding pattern Q3
Q4 Shareholding Pattern
Scroll to Top
